Fewer than 10% of cancer patients undergo hereditary testing — meaning the vast majority of high-risk individuals are never identified within standard clinical workflows.
VHC Health found a way to change that. By integrating a digital tool to automatically capture patient histories, apply NCCN guidelines and calculate breast cancer risk scores, the organization moved from manual, inconsistent workflows to a scalable, systematic approach.
The results: a 72% patient assessment completion rate, 620 high-risk patients identified and 49 positive genetic cases confirmed.
In this webinar, VHC Health's genetic counseling clinical manager walks through the model that made it possible and what it took to implement it — without overwhelming staff.
Key learning points:
- How to close the gap for women who qualify for risk-based breast MRI but go unidentified
- How digital tools automate NCCN guideline application and Tyrer-Cuzick scoring
- How VHC Health built a financially sustainable, high-risk program with measurable downstream impact
